A new study presented at the European Respiratory Society Conference in Vienna suggests that popular epilepsy drug Sulthiame may reduce major Obstructive Sleep Apnea (OSA) symptoms. According to ...

The drug sulthiame, normally used to treat epilepsy, appeared to reduce breathing pauses by more than 20 events an hour, on average, in obstructive sleep apnea patients, according to early ...

European epilepsy drug sulthiame could be an effective treatment for sleep apnea, a new study suggests. Photo by Adobe Stock/HealthDay News A European epilepsy drug could be an effective treatment ...

Sulthiame is currently used to treat childhood epilepsy. The post Epilepsy drug shows signs it can cure obstructive sleep apnea appeared first on Talker. ... and they may wake up several times.

Anti-Epilepsy Drug Improves Sleep Apnea Symptoms in Mid-Stage Trial ... The high responders may make up 30%-40% of patients, he estimated, and non-responders may be around 30%.

Treating obstructive sleep apnea in patients with epilepsy significantly reduces seizures, according to what's believed is the largest study of its kind to date. News & Perspective Drugs & Diseases ...

In clinical trials, GLP-1 drug tirzepatide reduced sleep apnea events by as much as two-thirds over the course of 52 weeks in patients with obstructive sleep apnea. Patients taking a placebo ...

Dubbed XEN1101, the new drug reduced the frequency of seizures by more than 50%, or even eliminated them, in some patients with focal epilepsy who did not respond to an average of six other drugs.

An epilepsy drug could cure a potentially deadly snoring condition, suggests a new study. Patients taking sulthiame - currently used for childhood epilepsy - in a clinical trial experienced a ...

An epilepsy drug could cure a potentially deadly snoring condition, suggests a new study. Patients taking sulthiame - currently used for childhood epilepsy - in a clinical trial experienced a ...